litlas
ログインアカウント作成

Richard A. Morgan

1966–2025 年に発表

107
論文数
44,208
被引用数
86
h 指数
105
i10 指数

被引用数

Richard A. Morgan の年別被引用数1977 年: 被引用 1 件1986 年: 被引用 2 件1990 年: 被引用 7 件1991 年: 被引用 20 件1992 年: 被引用 27 件1993 年: 被引用 23 件1994 年: 被引用 34 件1995 年: 被引用 32 件1996 年: 被引用 35 件1997 年: 被引用 36 件1998 年: 被引用 41 件1999 年: 被引用 43 件2000 年: 被引用 56 件2001 年: 被引用 68 件2002 年: 被引用 129 件2003 年: 被引用 130 件2004 年: 被引用 98 件2005 年: 被引用 101 件2006 年: 被引用 87 件2007 年: 被引用 145 件2008 年: 被引用 173 件2009 年: 被引用 186 件2010 年: 被引用 284 件2011 年: 被引用 290 件2012 年: 被引用 329 件2013 年: 被引用 597 件2014 年: 被引用 415 件2015 年: 被引用 657 件2016 年: 被引用 635 件2017 年: 被引用 753 件2018 年: 被引用 779 件2019 年: 被引用 1,817 件2020 年: 被引用 2,103 件2021 年: 被引用 2,009 件2022 年: 被引用 1,550 件2023 年: 被引用 1,222 件2024 年: 被引用 1,509 件2025 年: 被引用 769 件2026 年: 被引用 23 件1978〜1985 年は被引用が無いため表示していません1987〜1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 5,668 件、この内訳の 34.5%中国: 引用元論文 1,902 件、この内訳の 11.6%ドイツ: 引用元論文 1,155 件、この内訳の 7%イギリス: 引用元論文 967 件、この内訳の 5.9%イタリア: 引用元論文 685 件、この内訳の 4.2%フランス: 引用元論文 520 件、この内訳の 3.2%日本: 引用元論文 492 件、この内訳の 3%カナダ: 引用元論文 475 件、この内訳の 2.9%オランダ: 引用元論文 425 件、この内訳の 2.6%スペイン: 引用元論文 388 件、この内訳の 2.3%オーストラリア: 引用元論文 375 件、この内訳の 2.3%スイス: 引用元論文 351 件、この内訳の 2.1%
0%34.5%その他 18.4%

機関

分野

  • Medicine64.3%
  • Biochemistry, Genetics and Molecular Biology21.9%
  • Immunology and Microbiology11%
  • Engineering0.9%
  • Neuroscience0.5%
  • Agricultural and Biological Sciences0.3%
  • その他1.1%

トピック

  • CAR-T cell therapy research15.2%
  • Immunotherapy and Immune Responses6.5%
  • Virus-based gene therapy research5.7%
  • Immune Cell Function and Interaction5.3%
  • Pancreatic and Hepatic Oncology Research4.9%
  • Cancer Immunotherapy and Biomarkers4.4%
  • その他58%

共著者

全論文

検索で開く
  1. Genomic analyses identify molecular subtypes of pancreatic cancer

    著者: Peter J. Bailey, David K. Chang, Kátia Nones, Amber L. Johns, Ann‐Marie Patch, Marie‐Claude Gingras, David K. Miller, Angelika N. Christ, Timothy J. C. Bruxner, Michael C. Quinn, Craig Nourse, L. Charles Murtaugh, Ivon Harliwong, Senel Idrisoglu, Suzanne Manning, Ehsan Nourbakhsh, Shivangi Wani, J. Lynn Fink, Oliver Holmes, Venessa Chin, Matthew J. Anderson, Stephen H. Kazakoff, Conrad Leonard, Felicity Newell, Nick M. Waddell, Scott Wood, Qinying Xu, Peter J. Wilson, Nicole Cloonan, Karin S. Kassahn, Darrin F. Taylor, Kelly Quek, Alan J. Robertson, Lorena Pantano, Laura Mincarelli, Luis Navarro-Sánchez, Lisa Evers, Jianmin Wu, Mark Pinese, Mark J. Cowley, Marc D. Jones, Emily K. Colvin, Adnan M. Nagrial, Emily S. Humphrey, Lorraine A. Chantrill, Amanda Mawson, Jeremy L. Humphris, Angela Chou, Marina Pajic, Christopher J. Scarlett, Andreia V. Pinho, Marc Giry-Laterrière, Ilse Rooman, Jaswinder S. Samra, James G. Kench, Jessica A. Lovell, Neil D. Merrett, Christopher W. Toon, Krishna Epari, Nam Q. Nguyen, Andrew P. Barbour, Nikolajs Zeps, Kim Moran‐Jones, Nigel B. Jamieson, Janet Graham, Fraser R. Duthie, Karin A. Oien, Jane Hair, Robert Grützmann, Anirban Maitra, Christine A. Iacobuzio–Donahue, Christopher L. Wolfgang, Richard A. Morgan, Rita T. Lawlor, Vincenzo Corbo, Claudio Bassi, Borislav C. Rusev, Paola Capelli, Roberto Salvia, Giampaolo Tortora, Debabrata Mukhopadhyay, Gloria M. Petersen, Australian Pancreatic Cancer Genome Initiative, Donna M. Munzy, William E. Fisher, Saadia A. Karim, James R. Eshleman, Ralph H. Hruban, Christian Pilarsky, Jennifer P. Morton, Owen J. Sansom, Aldo Scarpa, Elizabeth A. Musgrove, Ulla‐Maja Bailey, Oliver Hofmann, Robert L. Sutherland, David A. Wheeler, Anthony J. Gill, Richard A. Gibbs, John V. Pearson ほか 3 名 - Nature 2016 被引用: 3,775

  2. Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

    著者: Noopur Raje, Jesús G. Berdeja, Yi Lin, David S. Siegel, Sundar Jagannath, Deepu Madduri, Michaela Liedtke, Jacalyn Rosenblatt, Marcela V. Maus, Ashley Turka, Lyh-Ping Lam, Richard A. Morgan, Kevin M. Friedman, Monica Massaro, Julie Wang, Greg Russotti, Zhihong Yang, Timothy Campbell, Kristen Hege, Fabio Petrocca, M. Travis Quigley, Nikhil C. Munshi, James N. Kochenderfer - New England Journal of Medicine 2019 被引用: 1,738

  3. Whole genomes redefine the mutational landscape of pancreatic cancer

    著者: Australian Pancreatic Cancer Genome Initiative, Nicola Waddell, Marina Pajic, Ann‐Marie Patch, David K. Chang, Karin S. Kassahn, Peter J. Bailey, Amber L. Johns, David S. Miller, Kátia Nones, Kelly Quek, Michael C. Quinn, Alan J. Robertson, Muhammad Zaki Hidayatullah Fadlullah, Timothy J. C. Bruxner, Angelika N. Christ, Ivon Harliwong, Senel Idrisoglu, Suzanne Manning, Craig Nourse, Ehsan Nourbakhsh, Shivangi Wani, Peter J. Wilson, Emma Markham, Nicole Cloonan, Matthew J. Anderson, J. Lynn Fink, Oliver Holmes, Stephen H. Kazakoff, Conrad Leonard, Felicity Newell, Barsha Poudel, Sarah Song, Darrin F. Taylor, Nick M. Waddell, Scott Wood, Qinying Xu, Jianmin Wu, Mark Pinese, Mark J. Cowley, Hong C. Lee, Marc D. Jones, Adnan Nagrial, Jeremy L. Humphris, Lorraine A. Chantrill, Venessa Chin, Angela Steinmann, Amanda Mawson, Emily S. Humphrey, Emily K. Colvin, Angela Chou, Christopher J. Scarlett, Andreia V. Pinho, Marc Giry-Laterrière, Ilse Rooman, Jaswinder S. Samra, James G. Kench, Jessica A. Pettitt, Neil D. Merrett, Christopher W. Toon, Krishna Epari, Nam Q. Nguyen, Andrew P. Barbour, Nikolajs Zeps, Nigel B. Jamieson, Janet Graham, Simone P. Niclou, Rolf Bjerkvig, Robert Grützmann, Daniela E. Aust, Ralph H. Hruban, Anirban Maitra, Christine A. Iacobuzio–Donahue, Christopher L. Wolfgang, Richard A. Morgan, Rita T. Lawlor, Vincenzo Corbo, Claudio Bassi, Massimo Falconi, Giuseppe Zamboni, Giampaolo Tortora, Margaret A. Tempero, Anthony J. Gill, James R. Eshleman, Christian Pilarsky, Aldo Scarpa, Elizabeth A. Musgrove, John V. Pearson, Andrew V. Biankin, Sean M. Grimmond - Nature 2015 被引用: 2,709

  4. Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2

    著者: Richard A. Morgan, James C. Yang, Mio Kitano, Mark E. Dudley, Carolyn M. Laurençot, Steven A. Rosenberg - Molecular Therapy 2010 被引用: 2,538

  5. Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma

    著者: Stephanie L. Goff, Richard A. Morgan, James C. Yang, Richard M. Sherry, Paul F. Robbins, Nicholas P. Restifo, Steven A. Feldman, Yong‐Chen Lu, Lily Lu, Zhili Zheng, Liqiang Xi, Monica Epstein, Lori McIntyre, Parisa Malekzadeh, Mark Raffeld, Howard A. Fine, Steven A. Rosenberg - Journal of Immunotherapy 2019 被引用: 376

  6. T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis

    著者: Maria R. Parkhurst, James C. Yang, Russell C. Langan, Mark E. Dudley, Debbie-Ann N. Nathan, Steven A. Feldman, Jeremy L. Davis, Richard A. Morgan, Maria J. Merino, Richard M. Sherry, Marybeth S. Hughes, Udai S. Kammula, Giao Q. Phan, Ramona M. Lim, Stephen A. Wank, Nicholas P. Restifo, Paul F. Robbins, Carolyn M. Laurençot, Steven A. Rosenberg - Molecular Therapy 2010 被引用: 1,014

  7. Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

    著者: James N. Kochenderfer, Wyndham H. Wilson, John E. Janik, Mark E. Dudley, Maryalice Stetler‐Stevenson, Steven A. Feldman, Irina Marić, Mark Raffeld, Debbie-Ann N. Nathan, Brock Lanier, Richard A. Morgan, Steven A. Rosenberg - Blood 2010 被引用: 1,335

  8. Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

    著者: Richard A. Morgan, Mark E. Dudley, John R. Wunderlich, Marybeth S. Hughes, James Chih‐Hsin Yang, Richard M. Sherry, Richard E. Royal, Suzanne L. Topalian, Udai S. Kammula, Nicholas P. Restifo, Zhili Zheng, Azam Nahvi, Christiaan R. de Vries, Linda Rogers-Freezer, Sharon Mavroukakis, Steven A. Rosenberg - Science 2006 被引用: 2,586

  9. Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy

    著者: Richard A. Morgan, Nachimuthu Chinnasamy, Daniel Abate‐Daga, Alena Gros, Paul F. Robbins, Zhili Zheng, Mark E. Dudley, Steven A. Feldman, James Chih‐Hsin Yang, Richard M. Sherry, Giao Q. Phan, Marybeth S. Hughes, Udai S. Kammula, Akemi D. Miller, Crystal J. Hessman, Ashley A. Stewart, Nicholas P. Restifo, Martha Quezado, Meghna Alimchandani, Avi Z. Rosenberg, Avindra Nath, Tongguang Wang, Bibiana Bielekova, Simone C. Wuest, Nirmala Akula, Francis J. McMahon, Susanne Wilde, Barbara Mosetter, Dolores J. Schendel, Carolyn M. Laurençot, Steven A. Rosenberg - Journal of Immunotherapy 2013 被引用: 1,145

  10. Adoptive cell transfer: a clinical path to effective cancer immunotherapy

    著者: Steven A. Rosenberg, Nicholas P. Restifo, James C. Yang, Richard A. Morgan, Mark E. Dudley - Nature reviews. Cancer 2008 被引用: 1,660

  11. Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia

    著者: Eric Tran, Dhanalakshmi Chinnasamy, Zhiya Yu, Richard A. Morgan, Chyi‐Chia Richard Lee, Nicholas P. Restifo, Steven A. Rosenberg - The Journal of Experimental Medicine 2013 被引用: 454

  12. Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma

    著者: Ling Zhang, Richard A. Morgan, Joal D. Beane, Zhili Zheng, Mark E. Dudley, Sadik H. Kassim, Azam Nahvi, Lien T. Ngo, Richard M. Sherry, Giao Q. Phan, Marybeth S. Hughes, Udai S. Kammula, Steven A. Feldman, Mary Ann Toomey, Sid P. Kerkar, Nicholas P. Restifo, James C. Yang, Steven A. Rosenberg - Clinical Cancer Research 2015 被引用: 452

  13. A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response

    著者: Paul F. Robbins, Sadik H. Kassim, Thai L.N. Tran, Jessica S. Crystal, Richard A. Morgan, Steven A. Feldman, James Chih‐Hsin Yang, Mark E. Dudley, John R. Wunderlich, Richard M. Sherry, Udai S. Kammula, Marybeth S. Hughes, Nicholas P. Restifo, Mark Raffeld, Chyi‐Chia Richard Lee, Yong F. Li, Mona El‐Gamil, Steven A. Rosenberg - Clinical Cancer Research 2014 被引用: 801

  14. Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

    著者: Paul F. Robbins, Richard A. Morgan, Steven A. Feldman, James C. Yang, Richard M. Sherry, Mark E. Dudley, John R. Wunderlich, Azam Nahvi, Lee J. Helman, Crystal L. Mackall, Udai S. Kammula, Marybeth S. Hughes, Nicholas P. Restifo, Mark Raffeld, Chyi‐Chia Richard Lee, Catherine Lévy, Yong F. Li, Mona El‐Gamil, Susan Schwarz, Carolyn M. Laurençot, Steven A. Rosenberg - Journal of Clinical Oncology 2011 被引用: 1,610

  15. B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells

    著者: James N. Kochenderfer, Mark E. Dudley, Steven A. Feldman, Wyndham H. Wilson, David Spaner, Irina Marić, Maryalice Stetler‐Stevenson, Giao Q. Phan, Marybeth S. Hughes, Richard M. Sherry, James C. Yang, Udai S. Kammula, Laura Devillier, Robert O. Carpenter, Debbie-Ann N. Nathan, Richard A. Morgan, Carolyn M. Laurençot, Steven A. Rosenberg - Blood 2011 被引用: 1,445

  16. Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

    著者: Laura A. Johnson, Richard A. Morgan, Mark E. Dudley, Lydie Cassard, James C. Yang, Marybeth S. Hughes, Udai S. Kammula, Richard E. Royal, Richard M. Sherry, John R. Wunderlich, Chyi‐Chia Richard Lee, Nicholas P. Restifo, Susan Schwarz, Alexandria P. Cogdill, Rachel Bishop, Hung Kim, Carmen C. Brewer, Susan F. Rudy, Carter VanWaes, Jeremy L. Davis, Aarti Mathur, R. Taylor Ripley, Debbie Nathan, Carolyn M. Laurençot, Steven A. Rosenberg - Blood 2009 被引用: 1,406

  17. AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines

    著者: Liyang Zhang, John A. Zuris, Ramya Viswanathan, Jasmine Edelstein, Rolf Turk, Bernice Thommandru, H. Tomas Rube, Steve E. Glenn, Michael A. Collingwood, Nicole M. Bode, Sarah F. Beaudoin, Swarali Surendra Lele, Sean Scott, Kevin Wasko, Steven Sexton, Christopher M. Borges, Mollie S. Schubert, Gavin Kurgan, Matthew McNeill, Cecilia A. Fernández, Vic E. Myer, Richard A. Morgan, Mark A. Behlke, Christopher A. Vakulskas - Nature Communications 2021 被引用: 172

  18. Construction and Preclinical Evaluation of an Anti-CD19 Chimeric Antigen Receptor

    著者: James N. Kochenderfer, Steven A. Feldman, Yangbing Zhao, Hui Xu, Mary A. Black, Richard A. Morgan, Wyndham H. Wilson, Steven A. Rosenberg - Journal of Immunotherapy 2009 被引用: 413

  19. Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia

    著者: Waleed Haso, Daniel W. Lee, Nirali N. Shah, Maryalice Stetler‐Stevenson, Constance M. Yuan, Ira Pastan, Dimiter S. Dimitrov, Richard A. Morgan, David J. FitzGerald, David M. Barrett, Alan S. Wayne, Crystal L. Mackall, Rimas J. Orentas - Blood 2012 被引用: 583

  20. T Lymphocyte-Directed Gene Therapy for ADA − SCID: Initial Trial Results After 4 Years

    著者: R. Michael Blaese, Kenneth W. Culver, A. Dusty Miller, Charles S. Carter, Thomas A. Fleisher, Mario Clerici, Gene M. Shearer, Lauren A. Chang, Ya‐Wen Chiang, Paul Tolstoshev, Jay J. Greenblatt, Steven A. Rosenberg, Harvey G. Klein, Melvin Berger, Craig A. Mullen, W. Jay Ramsey, Linda Muul, Richard A. Morgan, W. French Anderson - Science 1995 被引用: 1,519

  21. Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions

    著者: Paul F. Robbins, Yong F. Li, Mona El‐Gamil, Yangbing Zhao, Jennifer A. Wargo, Zhili Zheng, Hui Xu, Richard A. Morgan, Steven A. Feldman, Laura A. Johnson, Alan Bennett, Steven M. Dunn, Tara Mahon, Bent K. Jakobsen, Steven A. Rosenberg - The Journal of Immunology 2008 被引用: 385

  22. Effective Targeting of Multiple B-Cell Maturation Antigen–Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells

    著者: Kevin M. Friedman, Tracy E. Garrett, John Evans, Holly M. Horton, Howard J. Latimer, Stacie L. Seidel, Christopher Horvath, Richard A. Morgan - Human Gene Therapy 2018 被引用: 207

  23. Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice

    著者: Dhanalakshmi Chinnasamy, Zhiya Yu, Marc R. Theoret, Yangbing Zhao, Rajeev Shrimali, Richard A. Morgan, Steven A. Feldman, Nicholas P. Restifo, Steven A. Rosenberg - Journal of Clinical Investigation 2010 被引用: 252

  24. Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned

    著者: Richard A. Morgan, David Gray, Anastasia Lomova, Donald B. Kohn - Cell stem cell 2017 被引用: 244